Lee Financial’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-19
Closed -$2K 945
2022
Q3
$2K Sell
19
-10
-34% -$1.32K ﹤0.01% 663
2022
Q2
$4K Buy
+29
New +$3.95K ﹤0.01% 581
2022
Q1
Sell
-13
Closed -$2K 806
2021
Q4
$2K Hold
13
﹤0.01% 725
2021
Q3
$2K Buy
+13
New +$1.9K ﹤0.01% 604
2020
Q4
Sell
-43
Closed -$5K 487
2020
Q3
$5K Hold
43
﹤0.01% 461
2020
Q2
$5K Hold
43
﹤0.01% 430
2020
Q1
$3K Hold
43
﹤0.01% 405
2019
Q4
$5K Hold
43
﹤0.01% 410
2019
Q3
$5K Hold
43
﹤0.01% 418
2019
Q2
$4K Hold
43
﹤0.01% 441
2019
Q1
$4K Buy
+43
New +$3.73K ﹤0.01% 423

Other funds holding DGX

Lee Financial's DGX Position: Q4 2022 in Review

Lee Financial sold out of Quest Diagnostics (DGX) in Q4 2022, closing a stake of 19 shares — an estimated $2K sold.

Lee Financial first reported a position in DGX in Q1 2019 and held it in 11 quarters. The position peaked at $5K in Q3 2020. 879 funds tracked by Wall St. Rank hold DGX as of Q4 2022.

  • Lee Financial reported no remaining Quest Diagnostics position as of Q4 2022 after selling out during the quarter.
  • Lee Financial sold 19 Quest Diagnostics shares in Q4 2022, an estimated $2K.
  • Lee Financial first reported a position in Quest Diagnostics in Q1 2019 and held it in 11 quarters.
  • Lee Financial's Quest Diagnostics position peaked at $5K in Q3 2020.
  • 879 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2022.

Based on Lee Financial's 13F filing for Q4 2022, filed 9 Feb 2023.